Nasdaq agrx.

XBiotech Inc. (NASDAQ:XBIT) said its board has declared an extraordinary cash dividend of approximately $2.50 per share, or up to an aggregate of $75 million, to holders of its common stock. This ...Feb 27, 2023 · PRINCETON, N.J., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) (“Agile” or the “Company”), a women's healthcare company, today announced that it has received ... PRINCETON, N.J., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced the U.S. commercial launch of Twirla ® (levonorgestrel ...PRINCETON, N.J., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced the granting of a previously disclosed inducement award ...Detailed Share Price, Charts and News for Agile Therapeutics Inc [NASDAQ,AGRX]. Share Market Tools for Successful Investing. Global Share Market database ...

Nasdaq News: This is the News-site for the company Nasdaq on Markets Insider Indices Commodities Currencies Stocks

Nov 19, 2023 · NASDAQ:AGRX opened at $2.06 on Friday. The stock has a market capitalization of $5.17 million, a P/E ratio of -0.15 and a beta of 1.81. The company has a 50 day moving average price of $1.96 and a 200 day moving average price of $2.79. Agile Therapeutics has a fifty-two week low of $1.65 and a fifty-two week high of $16.00.

PRINCETON, N.J., Dec. 22, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (NASDAQ:AGRX), a women’s healthcare company, today announced that the U.S. Food and Drug Administration (FDA) issued ...Mar 21, 2023 · Follow. PRINCETON, N.J., March 21, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will report fourth quarter and full year 2022 ... PRINCETON, N.J., May 08, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will report first quarter 2023 financial results after ...Agile Therapeutics, Inc. (NASDAQ:AGRX) Q3 2023 Earnings Call Transcript November 9, 2023 Agile Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.27, expectations were $-1.58.Agile Therapeutics (NASDAQ: AGRX), a women's healthcare company, reported increasing Twirla prescription data for the first quarter 2022.Twirla cycles dispensed increased 29% to 16,602; Total ...

Jul 1, 2022 · PRINCETON, N.J., July 01, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) ("Agile Therapeutics" or the "Company"), a women's healthcare company, today announced the pricing of its ...

PRINCETON, N.J., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) (“Agile” or the “Company”), a women's healthcare company, today announced that it has received written notification from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) granting the Company’s request for a 180 …

The principal risks of investing in the Fund are: Market Risk. The market values of the Fund’s investments, and therefore the value of the Fund’s shares, will go up and down, sometimes rapidly or unpredictably. Market risk may affect a single issuer, industry or section of the economy, or it may affect the market as a whole.PRINCETON, N.J., May 04, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today reported financial results for the three months ended March 31, 2021 ...The principal risks of investing in the Fund are: Market Risk. The market values of the Fund’s investments, and therefore the value of the Fund’s shares, will go up and down, sometimes rapidly or unpredictably. Market risk may affect a single issuer, industry or section of the economy, or it may affect the market as a whole.Agile Therapeutics, Inc. (NASDAQ:AGRX) is a New Jersey-based healthcare company focused on catering to the unmet demands of women by offering them various contraceptive options.PRINCETON, N.J., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today reported financial results for the three months ended September 30 ...

Agile Therapeutics Inc (NASDAQ: AGRX ) ... The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs on ...PRINCETON, N.J., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today reported financial results for the three months ended June 30 ...Sep 28, 2023 · Nasdaq Futures. 15,953.25 ... (NASDAQ:AGRX) to a "buy" rating. Agile Therapeutics is a women's healthcare company that is "dedicated to fulfilling the unmet needs of today's women." Its product ... PRINCETON, N.J., Aug. 03, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a forward-thinking women’s healthcare company, today announced the pricing of its underwritten public ...PRINCETON, N.J., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced that it intends to offer and sell shares of its common ...PRINCETON, N.J., Aug. 02, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a forward-thinking women’s healthcare company, today announced that it intends to offer and sell shares ...Aug 9, 2023 · PRINCETON, N.J., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today reported financial results for the three months ended June 30 ...

(NASDAQ: AGRX) Agile Therapeutics stock price per share is $2.11 today (as of Nov 28, 2023). What is Agile Therapeutics's Market Cap? ( NASDAQ : AGRX ) Agile …PRINCETON, N.J., May 05, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today publicly released the findings of its first year of post-marketing ...

Find the latest Financials data for Agile Therapeutics, Inc. Common Stock (AGRX) at Nasdaq.com.May 19, 2023 · Find the latest SEC Filings data for Agile Therapeutics, Inc. Common Stock (AGRX) at Nasdaq.com. Feb 16, 2021 · Agile Therapeutics (NASDAQ:AGRX) is a commercial-stage pharmaceutical company selling its recently approved Twirla patch.I have followed the AGRX story for quite some time, first publishing "400% ... Apr 26, 2022 · The Company’s common stock will open for trading on the Nasdaq Market on Wednesday, April 27, 2022 on a split-adjusted basis under the current trading symbol "AGRX." Agile Therapeutics (NASDAQ:AGRX) is a commercial-stage pharmaceutical company selling its recently approved Twirla patch.I have followed the AGRX story for quite some time, first publishing "400% ...Based on analysts offering 12 month price targets for AGRX in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 .Agile Therapeutics, Inc. (NASDAQ:AGRX) Q3 2023 Earnings Call Transcript November 9, 2023 Agile Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.27, expectations were $-1.58.Agile Therapeutics (NASDAQ: AGRX), a women's healthcare company, reported increasing Twirla prescription data for the first quarter 2022.Twirla cycles dispensed increased 29% to 16,602; Total ...PRINCETON, N.J., Oct. 07, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that it has reorganized and streamlined its executive ...

Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced it will report first quarter 2021 financial results after the market close on Tuesday, May 4, 2021 as ...

G1 Therapeutics, Inc. (NASDAQ:GTHX) reported revenues of $14.2 million for the first quarter and its net loss per share narrowed from 82 cents to 65 cents. Analysts, on average, estimated a loss ...

PRINCETON, N.J., April 22, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a forward-thinking women’s healthcare company, today announced that the company has nominated Sharon ...Agile Therapeutics Inc (NASDAQ:AGRX) ... Institutional investors purchased a net $3.4 thousand shares of AGRX during the quarter ended June 2019 and now own 7.67% ...Agile Therapeutics Inc (NASDAQ:AGRX) Agile Therapeutics Inc. 1.90. Delayed Data. As of Nov 14. -0.02 / -1.04%. Today’s Change. 1.65. Today ||| 52-Week Range.Agile Therapeutics, Inc. Common Stock (AGRX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.PRINCETON, N.J., July 12, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of new ...Dec 1, 2023 · Agile Therapeutics (NASDAQ:AGRX) Now Covered by Analysts at StockNews.com americanbankingnews.com - November 26 at 2:52 AM: Agile Therapeutics (NASDAQ:AGRX) Stock Crosses Below 200 Day Moving Average of $2.67 americanbankingnews.com - November 25 at 3:54 AM: Agile Therapeutics reports Q3 results msn.com - November 23 at 8:51 AM NASDAQ: AGRX · IEX Real-Time Price · USD. Add to Watchlist 2.16 +0.09 (4.35%) Dec 1, 2023, 4:00 PM EST - Market closed. Overview; Financials; ... Stock Price Forecast. According to 2 stock analysts, the average 12-month stock price forecast for AGRX stock stock is $8.50, which predicts an increase of 293.52%. The lowest target is …Agile Therapeutics Inc. (AGRX) is down over 4% at $2.74 in pre-market hours Monday on no news. The company's birth control patch Twirla is expected to be launched this quarter.

Records 1 - 18 of 20 ... Find the latest historical data for Agile Therapeutics, Inc. Common Stock (AGRX) at Nasdaq.com.Agile Therapeutics, Inc. (NASDAQ: AGRX), the commercial-stage women’s healthcare company, posted a 122% increase in third-quarter revenue year-over-year, driven by strong demand for Twirla&#9415 ...Sep 27, 2023 · Maxim Group, a major investment bank, conducts and publishes stock analysis through its Equity Research team. The team has a strong reputation in the industry; a host of major firms use its ... Find real-time AGRX - Agile Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. Instagram:https://instagram. best immediate annuitiesfh marketdifference between spy and spxshell dutch stock Agile Therapeutics, Inc. Common Stock (AGRX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. AcelRx Pharmaceuticals, Inc. Common Stock (ACRX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. chwy stock forecastbest jewelry insurance policy Agile Therapeutics Inc. (NASDAQ: AGRX) During trading and after-hours, AGRX stock managed to shoot up by over 10% and 10.4% respectively. And, this is even more impressive following its six month drop of over 90%. For similar reasons that EVFM stock climbed, AGRX is a women’s health focused biotech penny stock. better stock Agile Therapeutics Inc (NASDAQ: AGRX) expects Q2 FY22 Twirla demand to be at the mid-point of the earlier provided outlook of 20,000 - 22,000 cycles (new range 21,000 - 21,500 cycles). It ...PRINCETON, N.J., July 08, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that Chairman and CEO Al Altomari will be participating in ...